ActiBiso™ IDBN —— Medical-grade antioxidant technology, remoulding skin's youthful strength

Ingredient traceability · Medical R&D background

Idebenone (IDBN) was first developed by Takeda Pharmaceutical Co., Ltd. in 1986 for the treatment of Alzheimer's disease, brain dysfunction and mental illness. Its molecular structure is derived from the modification of coenzyme Q10, and it has high lipophilicity and excellent biological activity, which can penetrate the blood-brain barrier and protect nerve cells.

In 2005, Swiss Santhera Pharmaceuticals and Takeda Pharmaceuticals reached a cooperation to promote the research, development and application of idebenone on a global scale. In 2007, Santhera became the first enterprise to submit an application for listing in idebenone. With the deepening of research, this "medical-grade molecule" has gradually expanded from the field of neuroprotection to the field of anti-aging skin care.

Brand Carrying · Sunland Pharmaceutical's scientific strength

Suzhou Sunland Pharmaceutical Technology Co., Ltd., established in 2019, is headquartered in Kunshan, Jiangsu Province, focusing on biomedical technology development, technical consulting and supply of high-end cosmetic raw materials.Adhering to the development concept of "scientific research as the core and innovation as the driving force", the company is committed to transforming medical-grade achievements into safe and efficient skin care solutions.

In this context, Sunland Pharmaceutical launched ActiBiso™ IDBN as the core antioxidant active ingredient, which empowers high-end skin care products with its profound medical traceability and advanced technology.

Scientific Advantages · Medically proven antioxidant "gold molecule"

The molecular weight of idebenone is about 340 Daltons, which is much smaller than the traditional coenzyme Q10 (863 Da), and its lower molecular weight allows it to efficiently penetrate the cuticle and reach the dermis. Experimental data show that:

Permeability:

85% of the activity remained in the dermis after 8 hours of application at the concentration of 0.5%.

Stability:

It can still maintain a high level of activity under multiple external environmental pressures.

Compared with common antioxidant components such as vitamin C, vitamin E and coenzyme Q10, idebenone shows more comprehensive and lasting antioxidant capacity and is known as "antioxidant Hermes".

Effect analysis · Triple anti-aging defense system

1. Efficiently remove free radicals

The ability to neutralize singlet oxygen is 10 times that of Coenzyme Q10, effectively reducing the damage to skin cells by oxidative stress.

2. Inhibit lipid peroxidation

Block free radical chain reaction, protect cell membrane integrity, and prevent damage to the skin barrier.

3. Activate the antioxidant cycle

By reducing oxidized vitamin C and E, a synergistic antioxidant network is formed to extend the antioxidant time.

4. Photodamage repair

Clinical data showed that for 8 consecutive weeks, the fine line density was reduced by 26% and the UV erythema area was reduced by 35%.

5. Anti-inflammatory and DNA protection

Reduce inflammatory responses caused by ultraviolet rays and external environment, reduce DNA damage, and resist photoaging from the root.

6. Improve dark skin tone

By inhibiting pigmentation induced by oxidation and inflammation, it significantly brightens the skin tone and enhances skin transparency.

Application Value · The core ingredients of high-end skin care

With its excellent antioxidant properties and medical background, ActiBiso™ IDBN is widely used in:

Anti-aging essence and face cream: repair photoaging and lighten fine lines and wrinkles

High-end sun protection products: Resist damage caused by ultraviolet rays and environmental pressure

Brightening and light spots: Improve uneven skin tone, dullness and pigmentation

Peripheral care: Reduce the damage of free radicals to fragile skin around the eyes and prevent the formation of fine lines.

ActiBiso™ IDBN —— Medical Verification · Science Selection

ActiBiso™ IDBN not only carries more than 30 years of medical research results, but also has become a trustworthy core component of high-end skin care brands under the technological empowerment of Suzhou Suland Pharmaceutical. It not only has unique advantages in fighting free radicals and photoaging, but also establishes a comprehensive antioxidant defense barrier for the skin through multiple mechanisms.

ActiBiso™ IDBN allows medical achievements to serve the skin and let the light of science illuminate the young future.